Effects of pharmacological treatments in alzheimer’s disease: Permutation entropy-based EEG complexity study

Yükleniyor...
Küçük Resim

Tarih

2023

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Springer

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

Alzheimer’s disease (AD) is a neurodegenerative brain disease affecting cognitive and physical functioning. The currently available pharmacological treatments for AD mainly contain cholinesterase inhibitors (AChE-I) and N-methyl-d-aspartic acid (NMDA) receptor antagonists (i.e., memantine). Because brain signals have complex nonlinear dynamics, there has been an increase in interest in researching complexity changes in the time series of brain signals in individuals with AD. In this study, we explore the electroencephalographic (EEG) complexity for making better observation of pharmacological therapy-based treatment effects on AD patients using the permutation entropy (PE) method. We examined EEG sub-band (delta, theta, alpha, beta, and gamma) complexity in de-novo, monotherapy (AChE-I), dual therapy (AChE-I and memantine) receiving AD participants compared with healthy elderly controls. We showed that each frequency band depicts its own complexity profile, which is regionally altered between groups. These alterations were also found to be associated with global cognitive scores. Overall, our findings indicate that entropy measures could be useful to show medication effects in AD.

Açıklama

Anahtar Kelimeler

Alzheimer’s disease, Dementia medications, EEG complexity, EEG frequencies, Permutation entropy

Kaynak

Brain Topography

WoS Q Değeri

N/A

Scopus Q Değeri

Q2

Cilt

36

Sayı

1

Künye

Fide, E., Polat, H., Yener, G. ve Özerdem, M. S. (2023). Effects of pharmacological treatments in alzheimer’s disease: Permutation entropy-based EEG complexity study. Brain Topography, 36(1), 106-118.